Actively Recruiting

Phase Not Applicable
Age: 18Years - 80Years
FEMALE
NCT05857631

Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study

Led by Tata Memorial Centre · Updated on 2025-04-15

90

Participants Needed

2

Research Sites

312 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The primary aim of the trial is to investigate the late effects of hypofractionated external radiation (39 Gy in 13 fractions) in patients requiring post-operative radiation for early-stage cervical and endometrial cancers.

CONDITIONS

Official Title

Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study

Who Can Participate

Age: 18Years - 80Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
  • Histologically confirmed cervical cancer after hysterectomy with intermediate or high-risk features needing adjuvant external beam radiation therapy with or without concurrent chemotherapy
  • Histologically confirmed endometrial cancer after hysterectomy requiring adjuvant chemotherapy and/or radiation to the pelvis with or without vaginal brachytherapy
Not Eligible

You will not qualify if you...

  • Presence of visible residual tumor after surgery (R+ resection)
  • Need for extended field radiotherapy due to involved para-aortic lymph nodes
  • Previous chemotherapy treatment for any cancer
  • Prior pelvic radiation therapy
  • Human immunodeficiency virus (HIV) infection
  • Existing medical conditions that could affect evaluation of genitourinary or gastrointestinal toxicity, such as irritable bowel syndrome, intestinal obstruction, anal incontinence, hemorrhoids, urinary incontinence, or recurrent urinary tract infections

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Advanced Centre for Treatment Research and Education in Cancer (ACTREC)

Navi Mumbai, Maharahstra, India, 410210

Actively Recruiting

2

Tata Memorial Hospital

Mumbai, Maharashtra, India, 400012

Actively Recruiting

Loading map...

Research Team

D

Dr. Prachi D Mittal, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here